Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/10/2010CN101278923B Potassium sodium dehydroandroan drographolide succinate microcapsule and method for preparing injection thereof
11/10/2010CN101269194B Medicament tincture for treating scobination type prurigo and preparation method thereof
11/10/2010CN101269164B Method of preparing virus bacterium blood serum Chinese aloe vaccine powder preparation and oral liquid for livestock, poultry biology and aquatic animal
11/10/2010CN101269122B Suction medicament for treating trigeminal neuralgia and preparation method thereof
11/10/2010CN101264239B Externally-applied powdered Chinese medicine for treating chronic sinusitis and nasal polyps and preparation thereof
11/10/2010CN101259265B Deep-sea fish collagen oral liquid
11/10/2010CN101254180B Nimodipine capsule containing semi-solid combination and preparation
11/10/2010CN101249154B Blood-nourishing nerve-soothing oral liquid
11/10/2010CN101244212B Bone fracture setting ointment for bone fracture concrescence
11/10/2010CN101244049B Clenbuterol hydrochloride double-layer sustained release tablets and preparation thereof
11/10/2010CN101235027B Xanthiphenylketamine crystal and its preparation method and medical use
11/10/2010CN101214295B Medicament for treating chicken infectivity laryngotracheitis
11/10/2010CN101199591B Soaking drug for treating limb kibe
11/10/2010CN101199508B Salvianic phenol acid or salt phospholipid compound and preparing method thereof
11/10/2010CN101198355B Agent for prevention or treatment of glaucoma
11/10/2010CN101185697B Ointment medicine for treating anal fissure
11/10/2010CN101185674B Infusion medicine for treating tinea pedis
11/10/2010CN101181460B Chinese medicine composition for curing gynecology inflammation and method of making the same
11/10/2010CN101181401B Chinese medicine medicament for curing empyrosis
11/10/2010CN101181259B Sustained-release agent of nitric acid dinitrate and preparation method thereof
11/10/2010CN101180062B Compound preparation for treating diabetes mellitus
11/10/2010CN101171249B Method for producing indole derivative having piperidine ring
11/10/2010CN101167797B American ginseng and ligusticum wallichii refreshment compound preparation
11/10/2010CN101157710B Method for preparing iron supplementary carboxymethyl Chitosan oligosaccharide ferrous
11/10/2010CN101134048B Medicament for preventing and treating alzheimer's disease and caducity
11/10/2010CN101129429B Technique of preparing traditional Chinese medicine xinkening formulated product
11/10/2010CN101121701B Five-membered rings 3-position single-substituted benzosultam derivatives and preparation method thereof
11/10/2010CN101120958B Medicinal preparation for treating liver cancer and leukemia and producing technology thereof
11/10/2010CN101116670B Application of compound capable of providing active methyl or of taking part in the diversion of methyl in the preparation of medicine for treating virosis
11/10/2010CN101112464B Plaster for treating parotitis and the preparing method thereof
11/10/2010CN101108192B Phenols glycosides compounds with liveness against osteosporosis
11/10/2010CN101098697B Compounds, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor
11/10/2010CN101090718B Complex formulation of 3-hydroxy-3-methyl glutaryl coa reductase inhibitor and antihypertensive agent, and process for preparing same
11/10/2010CN101085053B Quality control method for quick-acting antidiarrheal capsule
11/10/2010CN101083984B Therapeutic compositions for intranasal administration of ketorolac
11/10/2010CN101081250B Potygonum multiflorum thunb extract medicament for treating anemia and the preparing method thereof
11/10/2010CN101073621B Medicinal composition for treating rheumatic pain
11/10/2010CN101057892B Medicinal composition for treating vaginal diseases and its preparation method and application
11/10/2010CN101056621B Use of toremifene in preparing medicine for treating androgen-deprivation induced hot flush
11/10/2010CN101053598B Medicinal composition for treating cardio-cerebralvascular diseases and diabetes
11/10/2010CN101039902B Aminoalcohol derivatives
11/10/2010CN101032554B Medicine for curing frequently encountered disease caused by Huohan toxicum and the preparing method
11/10/2010CN101022788B Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
11/10/2010CN101005831B Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
11/10/2010CA2759843A1 Gpr 119 modulators
11/09/2010USRE41920 Isobutylgaba and its derivatives for the treatment of pain
11/09/2010US7829724 N-(1-(5-(2-(1H-indol-3-yl)ethyl)-4-(2,4-dimethoxybenzyl)-4H-1,2,4-triazol-3-yl)-2-(1H-indol-3-yl)ethyl)-2-amino-2-methylpropanamide; useful for treating growth retardation, cachexia, obesity, food intake, energy balance, tumor cell proliferation, wound/burn healing, metabolic disorders and inflammation.
11/09/2010US7829721 Therapy for diabetic retinopathy
11/09/2010US7829720 Process for preparing atazanavir bisulfate and novel forms
11/09/2010US7829719 [3-(6-Chloropyridin-3-yl)-2-methylpropyl](methyl)oxido- lambda 4-sulfanylidenecyanamide; aphidicides
11/09/2010US7829717 such as 3-[(Quinolin-4-ylmethyl)amino]-N-[4-methyl-3-(2-(4-(2-propyl)piperazin-1-yl)-3,4-dioxocyclobut-1-en-1-yl)phenyl]thiophene-2-carboxamide, having stem cell factor receptor inhibitory activity, used antitumor or anticarcinogenic agents
11/09/2010US7829716 decyclization of {3-[(E)-2(7-chloro-2-quinolinyl)vinyl]phenyl}-4,5-dihydro-3H-benzo[c]thiepin-1-one by methylmagnesium halide with following conversion to montelukast
11/09/2010US7829714 conjugated fluorescent dyes with a steroid; 3-oxo-N-(2-{[6-(9-oxoacridin-10(9H)-yl)hexanoyl]amino}ethyl)androst-4-ene-17-carboxamide; drug screening a test agent which modulate aromatase activity
11/09/2010US7829712 Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
11/09/2010US7829708 such as psoriasis and inflammatory bowel disease, in a human or other host animals; 2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid
11/09/2010US7829707 Pyrrolo [3,2-d]pyrimidin-4-one derivatives and their use in therapy
11/09/2010US7829705 such as 7-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-4-ethoxy-cinnoline, used in the treatment of picornavirus infections in humans
11/09/2010US7829694 surgerical insertion of catheter; supplying protein antagonistl Alzheimer's disease; Parkinson's disease; Huntington's disease; Spinocerebella atropy
11/09/2010US7829693 Compositions and methods for inhibiting expression of a target gene
11/09/2010US7829676 Whitefly ecdysone receptor antibody
11/09/2010US7829675 TWEAK receptor
11/09/2010US7829672 Modulation of sodium channels in dorsal root ganglia
11/09/2010US7829671 human endonuclease protein, MED1 (methyl-CpG binding endonuclease 1); drug screening; genetic or cancer screening assays
11/09/2010US7829669 Catalytically active recombinant memapsin and methods of use thereof
11/09/2010US7829664 encoding a human pro-insulin leader, a glucagon-like peptide-1 (GLP-1), and a furin cleavable site between the human pro-insulin leader sequence and the GLP-1; Type II diabetes, hyperglycemia; reducing weight in a subject by implanting into the subject an immunoisolatory device
11/09/2010US7829597 preventing the formation of insoluble A beta and arresting the production of A beta; beta-site amyloid precursor protein-cleaving enzyme; 3-[(2-amino-2-methyl-3-phenylpropoxy)methyl]-N-[(1R)-1-(4-fluorophenyl)ethyl]-[methyl(methylsulfonyl)amino]benzamide
11/09/2010US7829596 administering to the patient an effective amount of a xanthine oxidase inhibitor ( allopurinol, 7,8-dihydroneopterin, 5,6,7,8-tetrahydrobiopterin, leukopterin, xanthopterin, neopterin etc.) to reduce sympathetic nervous system activity and/or improving cardiovascular reflex status for treating cachexia
11/09/2010US7829595 A mixture of compound, e.g., cinacalcet hydrochloride and excipient in dosage form having a controlled dissolution profile , which comprises 50-125% of a target amount of theactive compound is released in 0.05 hydrochloric acid in 30 minutes; calcimimetics and calcilytics; hyperparathyroidism
11/09/2010US7829594 calcium receptor antagonists such as 3-{3,4-Difluoro-5-[(R)-2-hydroxy-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propoxyl]-phenyl}-propionic acid, used to increase serum parathyroid hormone levels in mammals
11/09/2010US7829593 Glutamine-containing compositions and a method for increasing blood flow using same
11/09/2010US7829592 e.g. 2-phenylcarbonyloxypropyl (2S)-2-amino-3-[3,4-bis(ethoxycarbonyloxy)phenyl]propanoate; neurodegenerative diseases; Parkinson's disease, depression, attention deficit disorder, schizophrenia; efficiently absorbed throughout gastrointestinal tract, including colon; sustained release
11/09/2010US7829591 Nymphaeol-A, nymphaeol-B and nymphaeol-C; microbiocide, antitumor agent, food, beverage and cosmetic preservative; antioxidant food supplement
11/09/2010US7829590 Polo-like kinase inhibitors such as 5-(5-Amino-2H-pyrazol-3-yl)-3-[1-(2-chloro-phenyl)-ethoxy]-thiophene-2-carboxylic acid amide, useful for treating or preventing autoimmune, inflammatory, proliferative or hyperproliferative disease, a neurodegenerative disease, or an immunologically-mediated disease
11/09/2010US7829589 growth hormone secretagogue receptor modulators such as (R)-3-(diethylamino)-N-(1-(3-(4-fluorophenyl)-1H-1,2,4-triazol-5-yl)-3-phenylpropyl)propane-1-sulfonamide, used for the treatment of diabetes, obesity, cardiovascular disease, stroke and as anticarcinogenic or antitumor agents
11/09/2010US7829588 Modulators of the PPAR-type receptors and pharmaceutical/cosmetic applications thereof
11/09/2010US7829587 adrenergic receptor agonists such as (8-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-yl)-propyl-pyridin-4-ylmethyl-amine, used as analgesics, decongestants, antidepressants and anxiolytic agents or for the treatment of vision defects, neurodegenerative diseases, diarrhea, attention deficit disorder, psychoses
11/09/2010US7829586 Aryl-substituted nitrogen-containing heterocyclic compounds
11/09/2010US7829585 such as 2-Amino-N-(5-ethoxymethyl-benzofuran-2-ylmethyl)-6-methoxymethyl-nicotinamide, used for treating a fungal infections; superior physical properties, safety and metabolic stability
11/09/2010US7829584 thrombin inhibitors such as 3-cyano-6-(2,2-difluoro-2-phenyl-ethylamino)-2-{2-[(aminoiminomethyl)aminooxy]ethyl}aminocarbonylmethyl-pyridine-1-oxide, used for the prophylaxis or treatment of diseases and conditions related to thrombin activity in mammals
11/09/2010US7829583 Biphenyl derivatives
11/09/2010US7829582 hydroxysteroid reductase inhibitors such as 4-{(R)-3-[3,5-Dichloro-4'-(4-trifluoromethyl-piperidine-1-carbonyl)-biphenyl-4-ylmethyl]-2-oxo-pyrrolidin-1-yl}-piperidine-1-carboxylic acid methyl ester, used for treating diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia and metabolic syndrome
11/09/2010US7829581 Prodrugs of pyrazoline compounds, their preparation and use as medicaments
11/09/2010US7829580 Cyclic amine derivative having heteroaryl ring
11/09/2010US7829579 Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase
11/09/2010US7829578 Aromatic ketones and uses thereof
11/09/2010US7829577 Voreloxin( SNS-595 ) and methanesulfonic acid ( for adjusting ph acidic) as anticarcinogenic agent
11/09/2010US7829576 Beloxepin and analogs for the treatment of pain
11/09/2010US7829575 Methods for treating androgen receptor related disorders
11/09/2010US7829574 compounds inhibit the activity of kinase insert domain receptor (KDR), such as 6-(6,7-bis(2-methoxyethoxy)quinazolin-4-yloxy)-N,2-dimethylbenzofuran-3-carboxamide, used for treating cancer, age-related macula degeneration or chronic inflammatory diseases
11/09/2010US7829573 Therapeutic combinations of antihypertensive and antiangiogenics agents
11/09/2010US7829572 Hypoparathyroidism, osteoporosis, osteopenia, periodontal disease, Paget's disease, bone fracture, osteoarthritis, rheumatoid arthritis, and humoral hypercalcemia of malignancy; e.g. (R)-3-(1-(3,4-difluorophenyl) propan-2-yl)-2-(3-hydroxypyridin-2-yl) 5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one
11/09/2010US7829571 monocyte chemotactic protein antagonists such as -(3S)-1-(4-(tert-butylamino)cyclohexyl)-3-(6-(trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-2-one, used for the treatment of asthma, multiple sclerosis, arteriosclerosis and rheumatoid arthritis
11/09/2010US7829570 Substituted 4-amino isoxazolo[5,4-d]pyrimidines as kinase inhibitors
11/09/2010US7829569 crystalline form of trans-1 {4-[2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl]-cyclohexyl}-3,3-dimethyl-urea hydrochloride (Form III) Cariprazine {RGH-188); Dysfunction of the dopaminergic neurotransmitter system is involved in the pathology of several neuropsychiatric and neurodegenerative disorders
11/09/2010US7829568 vanilloid receptor antagonists such as 2-({2-[butyl-(3-chlorobenzoyl)-amino]-5,6,7,8-tetrahydro-imidazo[1,2-a]pyridine-3-carbonyl}-amino)-3-methyl-benzyl butyrate, used as analgesics
11/09/2010US7829567 reacting a 11H-indeno[1,2-c]quinolin-11-one derivative with hydroxylamine, then alkylation with an alkyl halide to yield )-11H-indeno[1,2-c]quinolin-11-one oxime derivatives, such as 6-hydroxy-9-methoxy-11H-indeno[1,2-c]quinolin-11-one oxime, used in the treatment of cancers and tumors
11/09/2010US7829566 4-amino-quinazolines
11/09/2010US7829565 such as 5-{4-[4-(5-cyano-2,3-dihydro-1H-indol-3-yl)butyl]piperazin-1-yl}benzo-furan-2-carboxamide, used as antidepressant, anxiolytic, neuroleptic and/or hyportensive agents and for treating headaches, tardive dyskinesia, obsessive compulsive, sleep, eating, sexual and/or learning disorders
11/09/2010US7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/09/2010US7829563 sleep disorders; (R)-2-[(S)1-(5-chloro-2-methoxy-phenyl)-3-(6-trifluoromethyl-pyridin-3-yl)-propylamino]-2-(4-fluoro-phenyl)-N-methyl-acetamide
1 ... 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 ... 7860